Related Experiment Video
Updated: Oct 13, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis
1Department of Rehabilitation, The Second Hospital of Dalian Medical University, Dalian City, Liaoning Province, China.
Background:
Curcumin has a potential therapeutic role in ovarian cancer. However, whether curcumin plays anti-cancer role in ovarian cancer by mediating the circular RNA (circRNA)/microRNA (miRNA)/mRNA network is still unclear.
Methods:
The expression of circ-PLEKHM3, miR-320a, and suppressor of morphogenesis in genitalia 1 (SMG1) was detected via qRT-PCR. Cell viability, colony-formation ability and apoptosis were analyzed via cell counting kit-8 assay, colony formation analysis, and flow cytometry. Protein expression was measured using western blot. The in vivo experiments were performed using a xenograft model. Target association was evaluated via dual-luciferase reporter analysis and RIP assay.
Results:
Curcumin suppressed ovarian cancer cell proliferation and promoted apoptosis. Circ-PLEKHM3 was downregulated in ovarian cancer, and its expression could be promoted by curcumin treatment. Circ-PLEKHM3 overexpression exacerbated the effect of curcumin on ovarian cancer cell proliferation and apoptosis, as well as anti-tumor effect. MiR-320a was targeted by circ-PLEKHM3. The inhibition effect of circ-PLEKHM3 overexpression on cell proliferation and the enhancing effect on cell apoptosis could be reversed by miR-320a mimic. SMG1 was targeted by miR-320a, and its knockdown also reversed the regulation of miR-320a inhibitor on the proliferation and apoptosis of ovarian cancer cells. In addition, circ-PLEKHM3 could upregulate SMG1 expression via sponging miR-320a.
Conclusion:
Curcumin restrained proliferation and facilitated apoptosis in ovarian cancer by regulating the circ-PLEKHM3/miR-320a/SMG1 axis.
Insights
Curcumin inhibits ovarian cancer by regulating the circ-PLEKHM3/miR-320a/SMG1 pathway. This study clarifies curcumin
Area of Science:
- Molecular Oncology
- Biochemistry
Background:
- Curcumin shows potential in ovarian cancer therapy.
- The precise molecular mechanisms, particularly involving the circRNA/miRNA/mRNA network, remain unclear.
Purpose of the Study:
- To investigate the role of curcumin in ovarian cancer.
- To elucidate the involvement of the circ-PLEKHM3/miR-320a/SMG1 axis in curcumin's anti-cancer effects.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) for gene expression analysis.
- Cell viability, apoptosis, and colony formation assays.
- Western blot, dual-luciferase reporter assays, and RIP assays.
Main Results:
- Curcumin suppressed ovarian cancer cell proliferation and induced apoptosis.
- Circ-PLEKHM3 was downregulated in ovarian cancer and its expression was increased by curcumin.
- Circ-PLEKHM3 acts as a sponge for miR-320a, which targets SMG1, forming a regulatory axis.
Conclusions:
- Curcumin exerts anti-cancer effects in ovarian cancer by modulating the circ-PLEKHM3/miR-320a/SMG1 axis.
- This pathway represents a potential therapeutic target for ovarian cancer treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
MicroRNAs
Drugs that Stabilize Microtubules

